1. A card adapter for connecting a memory card (M) having the first electrode array (M1) and the second electrode array (M2) to a connector for memory cards which are different from the memory card (M) comprising:
a main body (50) having an insertion slot (51) into which the memory card (M) is inserted;
a first contact member (10) comprising first contact points (11) for contacting the first electrode array (M1) and first connecting portions (12) to be connected to the connector with base portions (13) disposed between the first contact points (11) and the first connecting portions (12); and,
a second contact member (20) comprising second contact points (21) for contacting the second electrode array (M2) and second connecting portions (22) to be connected to the connector with base portions (23) disposed between the second contact points (21) and the second connecting portions (22);
the first contact member (10) and the second contact member (20) being arranged within the main body (50) in such a way that the first contact points (11) and the second contact points (21) are located at different positions in a direction in which the memory card is inserted.
2. The card adapter according to claim 1, wherein the base portions (13) of the first contact member (10) and the base portions (23) of the second contact member (20) are located at different positions in a direction of thickness of the main body (50).
3. The card adapter according to claim 1, wherein the first contact member (10) and the second contact member (20) are embedded into the first insulator (30) and the second insulator (40) respectively by insertion molding, and the first insulator (30) and the second insulator (40) are assembled to be integrated.
4. The card adapter according to claim 3, wherein a convex portion (41) formed in the second insulator (40) is fit into a hole portion (31) formed in the first insulator (30) to integrate the first insulator (30) and the second insulator (40) wherein the first connecting portions (12) and the second connecting portions (22) lie in a common flat surface.
5. The card adapter of the claim 1, wherein the main body (50) comprises a metal case (52), which functions as a ground member of the memory card (M).
The claims below are in addition to those above.
All refrences to claim(s) which appear below refer to the numbering after this setence.
What is claimed is:
1. A method of treating ulcers with lansoprazole which comprises administering to a human a therapeutically effective amount of optically pure S()isomer of lansoprazole, or a pharmaceutically acceptable salt thereof.
2. A method of treating gastroesophageal reflux disease which comprises administering to a human a therapeutically effective amount of optically pure S()isomer of lansoprazole, or a pharmaceutically acceptable salt thereof.
3. A method of treating a condition caused by or contributed to by gastric hypersecretion which comprises administering to a human a therapeutically effective amount of optically pure S()isomer of lansoprazole, or a pharmaceutically acceptable salt thereof.
4. The method according to claim 3 wherein said condition is Zollinger-Ellison Syndrome.
5. A method of treating psoriasis which comprises administering to a human a therapeutically effective amount of optically pure S()isomer of lansoprazole, or a pharmaceutically acceptable salt thereof.
6. The method of any of claims 1-5 wherein () lansoprazole is administered orally.
7. The method of claim 6 wherein the amount of () lansoprazole or a pharmaceutically acceptable salt thereof administered is from about 5 mg to about 180 mg per day.
8. The method of claim 7 wherein the amount administered is from about 10 mg to about 60 mg per day.
9. The method of any of claims 1-5 wherein the amount of () lansoprazole or a pharmaceutically acceptable salt thereof is greater than approximately 90% by weight of the total weight of lansoprazole.
10. The method of any of claims 1-5 wherein the amount of () lansoprazole or a pharmaceutically acceptable salt thereof is greater than approximately 99% by weight of the total weight of lansoprazole.
11. A pharmaceutical composition comprising a pharmaceutically acceptable carrier for oral therapy and a therapeutically effective amount of () lansoprazole or a pharmaceutically acceptable salt thereof, substantially free of its () stereoisomer.
12. A pharmaceutical composition according to claim 11 in the form of a tablet or capsule.